BSECompany Update27 Aug 2026
Mercury Laboratories Ltd
Newspaper publication regarding 45th AGM to be held on September 28, 2026 is attached
Mercury Laboratories Ltd has announced the publication of a newspaper advertisement regarding its 45th Annual General Meeting (AGM) to be held on September 28, 2026, through Video Conference (VC) / Other Audio-Visual Means (OAVM).
BSECompany UpdateMgmt Change21 Aug 2026
Mercury Laboratories Ltd
Intimation regarding appointment of Mr. Sunil Sharma and resignation of Ms. Seema Salvi as HOD injectable
Mercury Laboratories Ltd has announced the appointment of Mr. Sunil Sharma as Head of the Department (Injectable Production) and the resignation of Ms. Seema Salvi from the same position, effective August 21, 2026.
BSECompany UpdateDividend20 Aug 2026
Mercury Laboratories Ltd
Communication to Shareholders on TDS on the dividend for the FY 25-26 is attached
Mercury Laboratories Ltd has announced a dividend of Rs. 3.5 per equity share for FY 2025-26, subject to shareholder approval at the AGM. The company will deduct tax at source at the prescribed rates on the dividend paid to its shareholders, with TDS rates varying depending on the residential status of the shareholder and the documents submitted.
BSECompany UpdateResults27 Jul 2026
Mercury Laboratories Ltd
Newspaper advertisement of unaudited financial result for the quarter ended on June 2026 is attched
Mercury Laboratories Ltd has published unaudited financial results for the quarter ended June 2026 in newspapers as per SEBI regulations.
BSEResultResults25 Jul 2026
Mercury Laboratories Ltd
Unaudited Financial results for the quarter ended on June 30, 2026 is attched
Mercury Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit after tax of ₹29.78 lakhs, a decrease from the previous quarter's ₹122.54 lakhs. The company's total income for the quarter was ₹1601.54 lakhs, with other income at ₹5.22 lakhs. The unaudited financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors on July 25, 2026.
BSEBoard MeetingResults25 Jul 2026
Mercury Laboratories Ltd
Outcome of meeting for approval of the unaudited financial statement for the quarter ended on June 30, 2026 is attched
Mercury Laboratories Ltd announced the outcome of its board meeting held on July 25, 2026, where it approved the unaudited financial results for the quarter ended June 30, 2026. The company's net profit after tax for the quarter was ₹29.78 crore, a decrease of 61.4% from the same quarter last year. The company's total income for the quarter was ₹1,601.54 crore, a decrease of 12.3% from the same quarter last year. The company's expenses for the quarter were ₹1,562.35 crore, a decrease of 7.3% from the same quarter last year.